Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Other Non-Current Liabilities: 2020-2023

Historic Other Non-Current Liabilities for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $433,000.

  • Candel Therapeutics' Other Non-Current Liabilities fell 90.64% to $433,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $433,000, marking a year-over-year decrease of 90.64%. This contributed to the annual value of $1.9 million for FY2022, which is 89.69% down from last year.
  • According to the latest figures from Q3 2023, Candel Therapeutics' Other Non-Current Liabilities is $433,000, which was down 57.30% from $1.0 million recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Other Non-Current Liabilities ranged from a high of $27.4 million in Q3 2021 and a low of $433,000 during Q3 2023.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $4.8 million (2022), whereas its average is $8.9 million.
  • In the last 5 years, Candel Therapeutics' Other Non-Current Liabilities soared by 167.19% in 2021 and then crashed by 90.64% in 2023.
  • Quarterly analysis of 4 years shows Candel Therapeutics' Other Non-Current Liabilities stood at $6.8 million in 2020, then soared by 167.19% to $18.3 million in 2021, then plummeted by 89.69% to $1.9 million in 2022, then crashed by 90.64% to $433,000 in 2023.
  • Its last three reported values are $433,000 in Q3 2023, $1.0 million for Q2 2023, and $1.2 million during Q1 2023.